256 related articles for article (PubMed ID: 9135409)
1. Atropine penalisation versus occlusion as the primary treatment for amblyopia.
Foley-Nolan A; McCann A; O'Keefe M
Br J Ophthalmol; 1997 Jan; 81(1):54-7. PubMed ID: 9135409
[TBL] [Abstract][Full Text] [Related]
2. Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.
Repka MX; Kraker RT; Holmes JM; Summers AI; Glaser SR; Barnhardt CN; Tien DR;
JAMA Ophthalmol; 2014 Jul; 132(7):799-805. PubMed ID: 24789375
[TBL] [Abstract][Full Text] [Related]
3. "Combined Occlusion and Atropine Therapy" Versus "Augmented Part-Time Patching" in Children with Refractory/Residual Amblyopia: A Pilot Study.
Sachdeva V; Mittal V; Gupta V; Gunturu R; Kekunnaya R; Chandrasekharan A; Chabblani PP; Rao HL
Middle East Afr J Ophthalmol; 2016; 23(2):201-7. PubMed ID: 27162453
[TBL] [Abstract][Full Text] [Related]
4. Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia.
Kaye SB; Chen SI; Price G; Kaye LC; Noonan C; Tripathi A; Ashwin P; Cota N; Clark D; Butcher J
J AAPOS; 2002 Oct; 6(5):289-93. PubMed ID: 12381987
[TBL] [Abstract][Full Text] [Related]
5. The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study.
Pediatric Eye Disease Investigator Group
Am J Ophthalmol; 2003 Oct; 136(4):630-9. PubMed ID: 14516802
[TBL] [Abstract][Full Text] [Related]
6. Compliance and patching and atropine amblyopia treatments.
Wang J
Vision Res; 2015 Sep; 114():31-40. PubMed ID: 25743080
[TBL] [Abstract][Full Text] [Related]
7. Amblyopia can be treated without occlusion or atropine.
Isenberg SJ
Ophthalmology; 2006 Jun; 113(6):893. PubMed ID: 16751031
[No Abstract] [Full Text] [Related]
8. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors.
Pediatric Eye Disease Investigator Group
Ophthalmology; 2003 Aug; 110(8):1632-7; discussion 1637-8. PubMed ID: 12917184
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years.
; Repka MX; Kraker RT; Beck RW; Holmes JM; Cotter SA; Birch EE; Astle WF; Chandler DL; Felius J; Arnold RW; Tien DR; Glaser SR
Arch Ophthalmol; 2008 Aug; 126(8):1039-44. PubMed ID: 18695096
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children.
Pediatric Eye Disease Investigator Group.
Arch Ophthalmol; 2002 Mar; 120(3):268-78. PubMed ID: 11879129
[TBL] [Abstract][Full Text] [Related]
11. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial.
Scheiman MM; Hertle RW; Kraker RT; Beck RW; Birch EE; Felius J; Holmes JM; Kundart J; Morrison DG; Repka MX; Tamkins SM;
Arch Ophthalmol; 2008 Dec; 126(12):1634-42. PubMed ID: 19064841
[TBL] [Abstract][Full Text] [Related]
12. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children.
Repka MX; Wallace DK; Beck RW; Kraker RT; Birch EE; Cotter SA; Donahue S; Everett DF; Hertle RW; Holmes JM; Quinn GE; Scheiman MM; Weakley DR;
Arch Ophthalmol; 2005 Feb; 123(2):149-57. PubMed ID: 15710809
[TBL] [Abstract][Full Text] [Related]
13. Amblyopia treatment and quality of life: the child's perspective on atropine versus patching.
Steel DA; Codina CJ; Arblaster GE
Strabismus; 2019 Sep; 27(3):156-164. PubMed ID: 31329017
[No Abstract] [Full Text] [Related]
14. Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children.
Menon V; Shailesh G; Sharma P; Saxena R
J AAPOS; 2008 Oct; 12(5):493-7. PubMed ID: 18534880
[TBL] [Abstract][Full Text] [Related]
15. PEDIG study on amblyopia; vision therapy by atropine penalization versus occlusion.
Kowal L
Binocul Vis Strabismus Q; 2002; 17(4):275. PubMed ID: 12470288
[No Abstract] [Full Text] [Related]
16. Randomized trial of treatment of amblyopia in children aged 7 to 17 years.
Scheiman MM; Hertle RW; Beck RW; Edwards AR; Birch E; Cotter SA; Crouch ER; Cruz OA; Davitt BV; Donahue S; Holmes JM; Lyon DW; Repka MX; Sala NA; Silbert DI; Suh DW; Tamkins SM;
Arch Ophthalmol; 2005 Apr; 123(4):437-47. PubMed ID: 15824215
[TBL] [Abstract][Full Text] [Related]
17. Conventional occlusion versus pharmacologic penalization for amblyopia.
Li T; Shotton K
Cochrane Database Syst Rev; 2009 Oct; (4):CD006460. PubMed ID: 19821369
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of penalization methods in moderate to mild amblyopia.
Tejedor J; Ogallar C
Am J Ophthalmol; 2008 Mar; 145(3):562-9. PubMed ID: 18207121
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the treatment of amblyopia.
Quinn GE; Beck RW; Holmes JM; Repka MX;
Pediatrics; 2004 Jun; 113(6):1800-2. PubMed ID: 15173508
[No Abstract] [Full Text] [Related]
20. Risk factors for treatment failure of anisometropic amblyopia.
Hussein MA; Coats DK; Muthialu A; Cohen E; Paysse EA
J AAPOS; 2004 Oct; 8(5):429-34. PubMed ID: 15492734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]